Protein crosslinkers, crosslinking methods and applications thereof
Some aspects of this disclosure relate to a method for crosslinking a biological fluid comprising combining a biological fluid with a crosslinker to covalently crosslink proteins endogenous to the biological fluid to form a crosslinked gel. Examples of a biological fluid are blood, plasma, or serum.
1. A low molecular weight precursor comprising: a biocompatible liquid crosslinker with a molecular weight of no more than about 2000 Daltons that comprises at least three activated acid functional groups that are strong electrophiles selected from the group consisting of succinimide, succinimide ester, N-hydroxysuccinimide ester and maleimide, wherein the crosslinker forms a melt at less than about 50° C., wherein the strong electrophiles are not reactable by a Michaels-type reaction.
2. The precursor of claim 1 , wherein the crosslinker is a polyethylene glycol derivative.
3. The precursor of claim 1 further comprising a hydrolytically degradable group.
4. The precursor of claim 1 , wherein the functional groups are N-hydroxysuccinimide or N-hydroxysulfosuccinimide.
5. The precursor of claim 1 , wherein the molecular weight is between about 300 and about 1000 Daltons.
6. The precursor of claim 1 , wherein the crosslinker is a melt at about 10° C. to about 50° C.
7. The precursor of claim 1 , wherein the crosslinker comprises polyethylene glycol.
8. The precursor of claim 1 , wherein the crosslinker consists essentially of a polyethylene glycol in which each of at least three end groups has been replaced with one of the functional groups.
9. The precursor of claim 8 wherein the crosslinker further comprises a hydrolytically degradable group.
10. The precursor of claim 9 wherein the functional groups are succinimides.
11. The precursor of claim 10 wherein the crosslinker is a melt at about 10° C. to about 50° C.
12. The precursor of claim 11 , wherein the molecular weight is between about 300 and about 1000 Daltons.